Dr. Mohamed Hosny El-Sayed, MD

Dr. El-Sayed practices at Broward Health Coral Springs in Coral Springs, Florida, part of North Broward Hospital District.

Dr. El-Sayed's NPI, 1316975550, was assigned on June 28, 2006. Dr. El-Sayed graduated from Ain Shams University Faculty of Medicine in 1980. Dr. El-Sayed holds Florida license ME63705.

Dr. El-Sayed's primary practice is Broward Health Coral Springs, at 3000 Coral Hills Dr, Coral Springs, FL 33065 in Broward County. The practice phone is (954) 344-3121.

Dr. El-Sayed's primary practice is Broward Health Coral Springs in Coral Springs, Florida, part of North Broward Hospital District. Dr. El-Sayed is also affiliated with HCA Florida Northwest Hospital. The medical group on file is Broward Health. Dmand AI also links Dr. El-Sayed to 2 more group practices and clinics, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. El-Sayed practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. El-Sayed's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. El-Sayed is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. El-Sayed's licenses on file in 5 states: Florida, California, Alabama, Louisiana and New Jersey.

Dmand AI lists aneurysm, atrial fibrillation and flutter, chronic hypertension, coronary artery disease, heart failure, heart valve disorders, high cholesterol and sick sinus syndrome among the conditions Dr. El-Sayed treats.

CMS data shows 1,678 Medicare services from Dr. El-Sayed across 11 procedure codes in 2024, for 475 Medicare patients. Medicare paid $116,228 for them.

CMS counts 475 Medicare patients who saw Dr. El-Sayed in 2024. The largest group is 75 to 84, with 179 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. El-Sayed's median patient age at 75, with 56% women.

In 2024, Dr. El-Sayed wrote 556 Medicare Part D claims for 113 patients. 78% of them were for generic drugs. CMS names the drug for 463 of them, across 14 drugs with 11 or more claims each, at $71,713 in total drug cost. In 2023, CMS named 299 claims across 14 drugs.

Dr. El-Sayed accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. El-Sayed.

Dmand AI links Dr. El-Sayed to 2 clinical trials. Conditions studied include Laryngomalacia and Cartilage Diseases. Boushahri Clinic Medical Center sponsors the most, 2.

CMS Open Payments shows 12 general payments to Dr. El-Sayed from 7 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 66% of the total. Astellas Pharma US Inc paid the most, $298.

Dr. El-Sayed graduated from Ain Shams University Faculty of Medicine in 1980.

Dr. El-Sayed is in network with 10 carriers, including Excellus BlueCross BlueShield, Blue Cross Blue Shield of Michigan and Cigna. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.